CECILIA ANN: Open Payments
NPI 1306212717 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 61 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $489 · 2025 $1,638
Food & beverage: $1,398Education: $240
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $306 |
| ABBVIE INC. | 15 | $295 |
| Arcutis Biotherapeutics, Inc. | 10 | $183 |
| Regeneron Healthcare Solutions, Inc. | 3 | $144 |
| Janssen Biotech, Inc. | 5 | $140 |
| Novartis Pharmaceuticals Corporation | 3 | $93 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| UCB, Inc. | 2 | $85 |
| LEO Pharma Inc. | 3 | $82 |
| Incyte Corporation | 2 | $58 |
Products named: DUPIXENT, Zoryve, RINVOQ, TREMFYA, SKYRIZI, COSENTYX, Bimzelx, ADBRY.
Industry payments across CA — which companies pay providers there.
